Moreover, the degranulation capacity of the CD56+CD16++ NK cell subset, known to be mainly responsible for NK cell cytotoxicity (37), remained stable throughout the whole time period until TP3, indicating that these NK cells were able to kill tumor cells at an early time point after SCT. This evidence concerns the gene NCAM1 and neoplasm.